BREA, Calif., US: Envista’s assisted intelligence (AI) mandibular nerve tracing feature in its image acquisition and diagnostic software platform DTX Studio Clinic has recently received 510(k) clearance from the US Food and Drug Administration (FDA). Commenting on the approval, Envista CEO Amir Aghdaei emphasised that this clearance is another important step for the company’s digital strategy of expanding the capabilities of the dental diagnostic software platform DTX Studio Clinic.
To manually trace the mandibular nerve can be time-consuming and sensitive to error. According to the company, the AI-assisted feature of the DTX Studio Clinic supports clinicians in performing this important task. Correct visualisation of the mandibular nerve is of high importance for modern dentistry as it has an impact on the patient’s treatment options and may prevent complications.
In a press release, Aghdaei explained how proud the company is of its fully automated mandibular nerve tracing functionality and its high clinical relevance for dental implant procedures. He said: “With its combination of a user-friendly interface and AI-driven functionality, DTX Studio Clinic reduces the time clinicians spend on time-consuming tasks, while simultaneously helping prevent complications and enabling increased focus on the patient.”
The current FDA clearance is preceded by the approval of Envista’s AI-driven 3D virtual tooth set-up algorithm in 2017 and its automatic tooth position identification and automated sorting of full-mouth radiographic series in 2020.
Tags:
BREA, Calif., US: Having divested its KaVo treatment unit and instrument business, Envista announced last week that its imaging segment will now be ...
BREA, Calif., US: Carestream Dental will sell its intra-oral scanner business to Envista Holdings in a deal that will cost the latter US$600 million ...
BREA, Calif., US: Envista, a dental equipment and supplies manufacturing company, has recently announced that it has closed the previously disclosed ...
Live webinar
Thu. 18 July 2024
8:00 pm EST (New York)
Live webinar
Tue. 6 August 2024
6:00 pm EST (New York)
Live webinar
Tue. 13 August 2024
7:00 pm EST (New York)
Live webinar
Wed. 21 August 2024
9:00 am EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 pm EST (New York)
Live webinar
Mon. 2 September 2024
5:00 am EST (New York)
Live webinar
Tue. 3 September 2024
11:00 am EST (New York)
To post a reply please login or register